INmune Bio
(NASDAQ:INMB)
$9.08
At close: Aug 17
$9.58
0.50[5.51%]
After Hours: 8:48AM EDT
Day High/Low- - -
52 Week High/Low4.63 - 11.78
Open / Close- / -
Float / Outstanding11.7M / 17.9M
Vol / Avg.- / 104.8K
Mkt Cap162.9M
P/E-
50d Avg. Price8.98
Div / Yield-
Payout Ratio-
EPS-0.38
Total Float11.7M

INmune Bio (NASDAQ:INMB), Quotes and News Summary

INmune Bio (NASDAQ: INMB)

Day High/Low- - -
52 Week High/Low4.63 - 11.78
Open / Close- / -
Float / Outstanding11.7M / 17.9M
Vol / Avg.- / 104.8K
Mkt Cap162.9M
P/E-
50d Avg. Price8.98
Div / Yield-
Payout Ratio-
EPS-0.38
Total Float11.7M
Sector: Health Care.Industry: Biotechnology
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-02
REV
Q2 2022Est.ActualSurprise
EPS-0.500-0.380 0.1200
REV16.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

INmune Bio Questions & Answers

Q
How do I buy INmune Bio (INMB) stock?
A

You can purchase shares of INmune Bio (NASDAQ: INMB) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are INmune Bio's (INMB) competitors?
Q
What is the target price for INmune Bio (INMB) stock?
A

The latest price target for INmune Bio (NASDAQ: INMB) was reported by BTIG on Tuesday, May 24, 2022. The analyst firm set a price target for 14.00 expecting INMB to rise to within 12 months (a possible 54.19% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for INmune Bio (INMB)?
A

The stock price for INmune Bio (NASDAQ: INMB) is $9.08 last updated August 17, 2022, 8:00 PM UTC.

Q
Does INmune Bio (INMB) pay a dividend?
A

There are no upcoming dividends for INmune Bio.

Q
When is INmune Bio (NASDAQ:INMB) reporting earnings?
A

INmune Bio’s Q3 earnings are confirmed for Wednesday, November 2, 2022.

Q
Is INmune Bio (INMB) going to split?
A

There is no upcoming split for INmune Bio.

Q
What sector and industry does INmune Bio (INMB) operate in?
A

INmune Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.